horizontal_bar
/// Pipeline

The company is interested in licensing technologies across all disease areas and types of therapeutics—small molecules, antibodies, proteins, cell therapies, and nucleotides.  BioMotiv is sourcing products from pre-clinical (lead optimization ready) through early clinical stages of development.
 

 

 

 

 


Click to view more

 

 

 

/// The Harrington Project

The Harrington Project for Discovery & Development is a $250 million national initiative to support the discovery and development of therapeutic breakthroughs by physician-scientists.  The Project is a new and powerful national model that addresses a set of major challenges in advancing medicine.

 

                 
h
      Click to view more

 

 

horizontal_bar